Ashland, MA, United States of America

Ishan Capila

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 105(Granted Patents)


Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Ishan Capila: Innovating Treatment Predictions for Rheumatoid Arthritis

Introduction

Ishan Capila, a prolific inventor based in Ashland, MA, is recognized for his significant contributions to the field of biotechnology. With a remarkable portfolio that encompasses 17 patents, Capila is driving innovations that aim to enhance treatment protocols for rheumatoid arthritis. His work emphasizes the importance of personalized medicine, particularly in predicting patient responses to therapies.

Latest Patents

Among his latest patents are groundbreaking methods for predicting response to treatment in rheumatoid arthritis patients. These methods involve assessing the levels of innate and adaptive immune cells in a patient's sample before commencing anti-TNF-alpha therapy. By understanding these cellular profiles, healthcare providers can better determine the likelihood of a positive response to treatment, thus optimizing patient care.

Career Highlights

Ishan Capila has collaborated with esteemed organizations throughout his career. Notably, he has worked with Momenta Pharmaceuticals, Inc. and the Massachusetts Institute of Technology. His roles in these institutions have played a pivotal part in expanding his research capabilities and furthering his innovative projects.

Collaborations

Throughout his journey, Ishan Capila has teamed up with notable professionals, including Daniela Beccati and Nur Sibel Gunay. These collaborations have fostered an environment of innovation and shared expertise, contributing significantly to his advancements in the field of immunology and treatment methodologies.

Conclusion

Ishan Capila exemplifies the spirit of innovation in the medical field, particularly in the realm of rheumatoid arthritis treatment. With his impressive patent portfolio and collaboration with leading organizations, he is paving the way for more effective personalized therapies. As his research continues to evolve, the impact of his work on patient care and treatment outcomes is expected to be substantial.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…